What is the diagnosis and recommended management for a patient with ferritin 6 µg/L, hemoglobin 10 g/dL, hematocrit 33 %, MCV 71 fL, MCH 21 pg, MCHC 29 g/dL, RDW 18 % and platelet count 436 ×10⁹/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis: Severe Microcytic Iron Deficiency Anemia

This patient has severe iron deficiency anemia (IDA) requiring immediate iron replacement therapy and comprehensive gastrointestinal evaluation to identify the source of blood loss.

Laboratory Interpretation

The laboratory values definitively establish IDA:

  • Ferritin 6 µg/L: Severely depleted iron stores (well below the diagnostic threshold of <45 ng/mL for IDA) 11
  • Hemoglobin 10 g/dL: Moderate anemia
  • MCV 71 fL, MCH 21 pg, MCHC 29 g/dL: Classic microcytic, hypochromic pattern
  • RDW 18%: Elevated, reflecting anisocytosis from mixed red cell populations
  • Platelets 436 ×10⁹/L: Reactive thrombocytosis (common in IDA from chronic blood loss)

The ferritin of 6 µg/L has 85% sensitivity and 92% specificity for iron deficiency, making this diagnosis essentially certain 2. The combination of low MCV, MCH, MCHC with elevated RDW and thrombocytosis strongly supports chronic iron deficiency rather than acute blood loss.

Immediate Management Algorithm

Step 1: Iron Replacement Therapy

Initiate oral iron supplementation immediately with ferrous sulfate, ferrous fumarate, or ferrous gluconate 11:

  • Dosing: Take on an empty stomach for optimal absorption
  • Enhance absorption: Co-administer with 500 mg vitamin C; taking with meat protein also improves uptake 11
  • If intolerant: Consider ferrous bisglycinate or take with meals (though absorption decreases)
  • Alternative: Given the severe deficiency (ferritin 6 µg/L) and moderate anemia, intravenous iron may be considered initially if oral iron is not tolerated or rapid repletion is needed 11

Step 2: Gastrointestinal Evaluation

Perform bidirectional endoscopy (EGD and colonoscopy) at the same setting 2:

This strong recommendation applies to:

  • Postmenopausal women
  • All men (regardless of age)
  • After excluding other obvious causes

Before endoscopy, evaluate:

  • Dietary iron intake (vegetarian/vegan diet)
  • Menstrual history (if premenopausal woman)
  • Frequent blood donation
  • Medications (NSAIDs, anticoagulants)
  • Helicobacter pylori infection 11

The elevated platelet count (436) and severe iron deficiency suggest chronic GI blood loss as the most likely etiology, making endoscopic evaluation essential to prevent ongoing blood loss and identify potentially serious pathology (malignancy, inflammatory bowel disease, celiac disease, vascular ectasias) 2.

Step 3: Treatment Targets

Monitor and aim for:

  • Hemoglobin: 12-13 g/dL (normalization)
  • Ferritin: >100 µg/L (though some guidelines suggest >200 µg/L) 3
  • Continue iron supplementation for 3-6 months after normalization to replenish stores

Critical Pitfalls to Avoid

  1. Do not delay GI evaluation: The combination of severe IDA with thrombocytosis mandates investigation for occult GI bleeding or malignancy
  2. Do not assume dietary deficiency alone: Ferritin this low (6 µg/L) in adults typically indicates blood loss, not just poor intake
  3. Do not use inflammatory markers as exclusion: While ferritin can be falsely elevated in inflammation, a ferritin of 6 µg/L confirms iron deficiency regardless of inflammatory state 11
  4. Monitor compliance: Oral iron side effects (nausea, constipation, abdominal pain) cause poor adherence—switch to IV iron if oral therapy fails 11

Additional Considerations

If the patient has inflammatory conditions (IBD, chronic kidney disease), the ferritin threshold interpretation changes, but at 6 µg/L, iron deficiency is unequivocal. Consider checking transferrin saturation or soluble transferrin receptor only if ferritin were in the 45-100 µg/L range with suspected inflammation 11.

Multidisciplinary involvement with gastroenterology is mandatory for endoscopic evaluation and source identification. Hematology consultation may be needed if anemia fails to respond to iron replacement or if additional causes are suspected 1.

Related Questions

In a male patient with hemoglobin 12.9 g/dL, low mean corpuscular volume (MCV) and low mean corpuscular hemoglobin (MCH), normal mean corpuscular hemoglobin concentration (MCHC), serum ferritin 586 µg/L, and RDW‑CV 16.9 %, what is the most likely diagnosis and what initial work‑up and management steps should be taken?
What is the appropriate treatment and diagnostic workup for a patient with mild anemia (hemoglobin 11.5 g/dL, hematocrit 35.1 %), normal mean corpuscular volume (93 fL), red cell distribution width 13.5 % and ferritin <5 ng/mL?
In a 64-year-old woman with ferritin 306 ng/mL, hemoglobin 12.9 g/dL, serum iron 54 µg/dL, TIBC 250 µg/dL, iron saturation 22 % while taking ferrous sulfate (325 mg) daily, and an isolated serum chloride of 107 mmol/L, should I stop the iron supplement and how should I address the elevated chloride?
What is the appropriate management for a 20-year-old female with mean corpuscular hemoglobin 26.5 pg, ferritin 24 ng/mL, and hemoglobin 13.2 g/dL?
What is the appropriate treatment and workup for a 41-year-old woman with low mean corpuscular hemoglobin (MCH 25.3 pg) and low ferritin (11 ng/mL)?
What fish‑oil supplement and dosage should be used to improve tear film stability/eye hydration in a patient already using Restasis (cyclosporine ophthalmic solution) twice daily and Hycosan artificial tears as needed?
What is the recommended dosing schedule for carbamazepine in adults, children, and elderly patients with seizures?
How should sertraline be tapered in a patient taking 100 mg daily who is also on duloxetine 20 mg twice daily for chronic neuropathic pain—should it be discontinued abruptly or reduced gradually?
Is delivering in the seventh month (28–31 weeks gestation) versus the eighth month (32–35 weeks gestation) more risky for the newborn’s breathing, and is this risk factual or a myth?
What are the common dosing regimens for cefazolin (Ancef) in adults and children, including adjustments for normal renal function, moderate renal impairment, and severe renal impairment?
What is the recommended evaluation and management when immunohistochemistry shows loss of MLH1, MSH2, and MSH6 expression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.